about
Intravenous alpha-1 antitrypsin augmentation therapy for treating patients with alpha-1 antitrypsin deficiency and lung diseaseMeta-analyses of genome-wide association studies identify multiple loci associated with pulmonary functionCOPD immunopathologyCandidate genes for COPD: current evidence and researchIs there a therapeutic role for selenium in alpha-1 antitrypsin deficiency?Progress with Recombinant Adeno-Associated Virus Vectors for Gene Therapy of Alpha-1 Antitrypsin DeficiencyThe Art and Science of Diagnosing and Treating Lung and Heart Disease Secondary to Liver DiseaseAlpha-1 antitrypsin deficiency targeted testing and augmentation therapy: a Canadian Thoracic Society clinical practice guidelineThe impact of age on outcomes in chronic obstructive pulmonary disease differs by relationship statusRisk loci for chronic obstructive pulmonary disease: a genome-wide association study and meta-analysis.Genome-wide association study identifies BICD1 as a susceptibility gene for emphysema.Differentially expressed serum proteins associated with calcium regulation and hypocalcemia in dairy cows.Sulfatase modifying factor 1 (SUMF1) is associated with Chronic Obstructive Pulmonary Disease.Segmenting by risk perceptions: predicting young adults' genetic-belief profiles with health and opinion-leader covariatesImpact of a functional polymorphism in the PAR-1 gene promoter in COPD and COPD exacerbationsNeutrophil elastase, proteinase 3, and cathepsin G as therapeutic targets in human diseases.Integrative genomics of chronic obstructive pulmonary disease.Identification of a chronic obstructive pulmonary disease genetic determinant that regulates HHIP.Targeting intracellular degradation pathways for treatment of liver disease caused by α1-antitrypsin deficiencyA review of augmentation therapy for alpha-1 antitrypsin deficiency.Three new alpha1-antitrypsin deficiency variants help to define a C-terminal region regulating conformational change and polymerization.α1 Antitrypsin deficiency: current best practice in testing and augmentation therapy.A novel SERPINA1 mutation causing serum alpha(1)-antitrypsin deficiency.Intravenous alpha-1 antitrypsin augmentation therapy for treating patients with alpha-1 antitrypsin deficiency and lung disease.Variants in the 15q24/25 locus associate with lung function decline in active smokers.Preclinical evaluation of a recombinant adeno-associated virus vector expressing human alpha-1 antitrypsin made using a recombinant herpes simplex virus production methodGenetic determinants of hepatic steatosis in man.Alpha 1-antitrypsin retention in an ectopic liver.Genetic variation in HTR4 and lung function: GWAS follow-up in mouse.Telomerase mutations in smokers with severe emphysema.Why has it been so difficult to prove the efficacy of alpha-1-antitrypsin replacement therapy? Insights from the study of disease pathogenesisPhase 2 clinical trial of a recombinant adeno-associated viral vector expressing α1-antitrypsin: interim results.Identification of a novel SERPINA-1 mutation causing alpha-1 antitrypsin deficiency in a patient with severe bronchiectasis and pulmonary embolismAlpha-1-antitrypsin monotherapy reduces graft-versus-host disease after experimental allogeneic bone marrow transplantation.Advances in understanding the pathogenesis of graft-versus-host disease.Diagnosis and management of patients with α1-antitrypsin (A1AT) deficiency.Genetic, host, and environmental interactions in a 19 year old with severe chronic obstructive lung disease; observations regarding the pathophysiology of airflow obstructionRelation between circulating CC16 concentrations, lung function, and development of chronic obstructive pulmonary disease across the lifespan: a prospective study.Heparan sulfate, an endogenous TLR4 agonist, promotes acute GVHD after allogeneic stem cell transplantationThe effects of weekly augmentation therapy in patients with PiZZ α1-antitrypsin deficiency.
P2860
Q24236795-30931192-E18A-470C-8C8B-1264867C9322Q24633262-C87298F5-349D-4688-8D7B-5BF5D9F0A7FFQ26749575-2E73547E-E7FB-42F5-8FBE-9BD086DE4E74Q26777324-AC04183C-B0AA-48AE-84B1-50D1F529B38BQ26851374-E326D428-B2E7-4DF8-BC91-FB99164FA870Q28085148-87B756F5-C500-4444-B4E1-F7D70040D26EQ28086776-A5AB789B-546B-47DA-9591-9716DDDD896CQ28385458-93ABAC7C-FA41-4E5C-8EC6-05ABA7936DD0Q28388561-F5BAEB10-51C9-4FA2-925F-50CFEAAEB715Q29416987-6C24D4AB-6B4F-4729-BEE0-E1AEA6566D73Q29416999-47C794CA-D9A2-474F-AB08-03627D798ECBQ33622921-78201EF1-45E8-432E-B908-67CF9D2CAADDQ33630586-EC0274F4-E237-4395-9E3B-C58626CDEB0AQ33773666-3566A5A6-8F1C-4B01-A98B-B63F701BB6D3Q34062965-79415689-E9B0-4338-83F4-BC9239E977CCQ34149948-AD714B08-D708-4DAB-95DD-F53DBE7803E8Q34232677-7F003FDA-21BB-452A-ACB0-6ED2FDC9532FQ34238083-4AF9725F-4015-4E79-99F8-6F1C2090D54FQ34241393-EBC99FF3-DE3B-47C8-B909-EDBB1CF81FCFQ34268108-744AEE1C-5643-463F-9EBA-39C3D52F255BQ34313851-2FEB9CD3-D45F-4CC0-87E4-CCFA14372B56Q34428735-B26653C1-1805-4D34-B868-68EF8699B0F7Q34517185-11BCCBCD-83FC-49EE-9463-DF655FCD365AQ34540664-52A29CDD-67F8-4285-BA5A-7D5715195E75Q34562154-7E050C26-4E51-4480-B964-306056219C62Q34589262-73803422-DF61-4FB8-8ABA-2C8E7A4ECC6FQ34646183-C0BB57DB-1575-403E-9654-38A690087955Q34677597-0E75AA8F-8303-4CA6-B01D-051D24446831Q34847876-F781D64F-F657-4873-BD4D-758CC3523A5DQ35056698-D8357252-6A7B-4DCD-A491-75FF1B4CE3EAQ35233352-1B34615C-9169-4A6F-B275-31905CC518E6Q35496285-F56F88C1-2F49-4803-B1AB-2B6B4B4BA80CQ35596461-833BCB9C-097F-40E4-9CAF-CD7BEEB04BDDQ35673668-8EDCD49F-F61E-473A-92FC-C072D0A0A904Q35971439-85E4EF8B-F7A5-450E-8A81-89C817A55CF5Q35989681-D718E44A-EF65-4088-BF71-740266BB6363Q36086157-2E05B49D-C533-4C83-B2E7-56CADFA1B065Q36268923-F91EADFA-9054-498E-A3B9-F01BDFFD41DFQ36305350-B70BB148-C6B3-4602-8163-669DC370A32EQ36308010-E5B18193-5DE1-411A-96FB-A3B8FE85C233
P2860
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Clinical practice. Alpha1-antitrypsin deficiency.
@ast
Clinical practice. Alpha1-antitrypsin deficiency.
@en
Clinical practice. Alpha1-antitrypsin deficiency.
@nl
type
label
Clinical practice. Alpha1-antitrypsin deficiency.
@ast
Clinical practice. Alpha1-antitrypsin deficiency.
@en
Clinical practice. Alpha1-antitrypsin deficiency.
@nl
prefLabel
Clinical practice. Alpha1-antitrypsin deficiency.
@ast
Clinical practice. Alpha1-antitrypsin deficiency.
@en
Clinical practice. Alpha1-antitrypsin deficiency.
@nl
P356
P1476
Clinical practice. Alpha1-antitrypsin deficiency.
@en
P2093
Edwin K Silverman
Robert A Sandhaus
P304
P356
10.1056/NEJMCP0900449
P407
P577
2009-06-01T00:00:00Z